TREMEAU PHARMACEUTICALS
Tremeau Pharmaceuticals is a Massachusetts based privately funded clinical stage company focused on commercializing non-opioid pain therapies targeting serious rare diseases impacted by the cyclooxygenase (COX) or prostanoid pathways. They focus exclusively on orphan or unique disease states with high unmet medical need.
TREMEAU PHARMACEUTICALS
Industry:
Clinical Trials Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tremeaurx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Route 53 Amazon CloudFront
Current Employees Featured
BRADFORD SIPPY
BRADFORD SIPPY Chairman & CEO @ Tremeau Pharmaceuticals Chairman & CEO 2016-07-01
Mark Corrigan
Mark Corrigan Co-Founder & President of research and development @ Tremeau Pharmaceuticals Co-Founder & President of research and development 2017-04-01
Founder
BRADFORD SIPPY
Mark Corrigan
Investors List
Gurnet Point Capital
Gurnet Point Capital investment in Private Equity Round - Tremeau Pharmaceuticals
Official Site Inspections
http://www.tremeaurx.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...